Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT03280043 Completed - Hemorrhage Clinical Trials

Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty.

Start date: September 1, 2015
Phase: N/A
Study type: Observational

The investigators hope to answer the question, "does ketorolac increase the risk of hematoma after reduction mammoplasty?" using a case-control study. All patients who developed a hematoma post reduction mammoplasty (cases) at our institution, and match these with women who had an uncomplicated reduction mammoplasty (controls), and then compare frequency of ketorolac exposure between these two groups as the primary outcome. If ketorolac increases the risk of hematoma, one should expect cases to have been exposed to ketorolac more frequently than controls. Based on previously existing literature, the investigators hypothesize that cases and controls will not differ in their ketorolac exposure, that is, ketorolac does not increase the risk of hematoma.

NCT ID: NCT03273322 Completed - Atrial Fibrillation Clinical Trials

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

ADRIFT
Start date: September 13, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Evaluation of 2 doses of rivaroxaban (10 and 15 mg) compared to dual anti platelet therapy (aspirin+clopidogrel) after left atrial appendage closure. The patients will be assessed at 10 and 90 days: central laboratory hemostasis analysis and clinical events assessment.

NCT ID: NCT03271697 Not yet recruiting - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage

AMASH
Start date: September 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This research is trying to see if AM can enhance the clinical prognosis for spontaneous aneurysm ruptured subarachnoid hemorrhage patients.

NCT ID: NCT03271489 Active, not recruiting - Uterine Fibroids Clinical Trials

Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

Start date: January 4, 2017
Phase: Phase 3
Study type: Interventional

This is phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. This study is double-blinded in the first year and an open-label for the next three years.

NCT ID: NCT03267615 Recruiting - Liver Cirrhosis Clinical Trials

VICIS - Vienna Cirrhosis Study

VICIS
Start date: February 1, 2017
Phase:
Study type: Observational [Patient Registry]

Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial. Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital. This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.

NCT ID: NCT03267446 Recruiting - Clinical trials for Antepartum Hemorrhage

Doppler Imaging and Morbidly Adherent Placenta

Start date: August 29, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to assess the value of adding 3D power Doppler (as a diagnostic technique) to gray scale technique in the antenatal diagnosis of morbidly adherent placenta as well as predict the surgical outcome regarding the type of surgery and the intra operative morbidities.

NCT ID: NCT03265990 Not yet recruiting - Clinical trials for Ligature; Hemorrhage

Haemorrhoidectomy by Ligasure and Conventional Surgery

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

Comparison between Haemorrhoidectomy by Ligasure and conventional surgery

NCT ID: NCT03264781 Recruiting - Uterine Bleeding Clinical Trials

The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users

Start date: August 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine that once-a-month injectable contraceptive( Cyclofem® ) has the effect on treatment of irregular uterine bleeding in implant contraceptive users or not.

NCT ID: NCT03261284 Active, not recruiting - Thrombosis Clinical Trials

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

DIAMOND
Start date: March 1, 2019
Phase: N/A
Study type: Interventional

This was a prospective, cohort study.

NCT ID: NCT03260153 Recruiting - Clinical trials for Intracerebral Hemorrhage

Deproteinised Calf Blood Serum Injection for the Treatment of Acute Intracerebral Hemorrhage

Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of Deproteinised Calf Blood Serum Injection in alleviating perihematomal edema (PHE) and secondary brain injury, as well as neurologic deficits in patients with acute intracerebral hemorrhage (ICH).